366 related articles for article (PubMed ID: 34367840)
1. Fibrinogen: A Feasible Biomarker in Identifying the Severity and Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mohan M; Parthasarathi A; S K C; Biligere Siddaiah J; Mahesh PA
Cureus; 2021 Aug; 13(8):e16864. PubMed ID: 34367840
[TBL] [Abstract][Full Text] [Related]
2. A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations.
Motegi T; Jones RC; Ishii T; Hattori K; Kusunoki Y; Furutate R; Yamada K; Gemma A; Kida K
Int J Chron Obstruct Pulmon Dis; 2013; 8():259-71. PubMed ID: 23754870
[TBL] [Abstract][Full Text] [Related]
3. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.
Oga T; Tsukino M; Hajiro T; Ikeda A; Nishimura K
Int J Chron Obstruct Pulmon Dis; 2011; 6():521-6. PubMed ID: 22069363
[TBL] [Abstract][Full Text] [Related]
4. The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.
Kim J; Lee CH; Hwang SS; Kim DK; Yoon HI; Lee SH; Kim KU; Kim EK; Kim TH; Lee JH; Oh YM; Lee SD
Respiration; 2019; 98(6):495-502. PubMed ID: 31665736
[TBL] [Abstract][Full Text] [Related]
5. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbation of COPD during pulmonary rehabilitation: outcomes and risk prediction.
Herer B; Chinet T
Int J Chron Obstruct Pulmon Dis; 2018; 13():1767-1774. PubMed ID: 29881266
[TBL] [Abstract][Full Text] [Related]
7. Prognostic assessment in COPD without lung function: the B-AE-D indices.
Boeck L; Soriano JB; Brusse-Keizer M; Blasi F; Kostikas K; Boersma W; Milenkovic B; Louis R; Lacoma A; Djamin R; Aerts J; Torres A; Rohde G; Welte T; Martinez-Camblor P; Rakic J; Scherr A; Koller M; van der Palen J; Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Tamm M; Stolz D
Eur Respir J; 2016 Jun; 47(6):1635-44. PubMed ID: 27103389
[TBL] [Abstract][Full Text] [Related]
8. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
10. Correlation of BODE index with quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients - A prospective study.
Kamath S; Kumar A; Panda SK; Samanta RP
J Family Med Prim Care; 2020 Nov; 9(11):5606-5613. PubMed ID: 33532403
[TBL] [Abstract][Full Text] [Related]
11. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease.
Ju CR; Liu W; Chen RC
Dis Markers; 2012; 32(5):281-7. PubMed ID: 22674408
[TBL] [Abstract][Full Text] [Related]
12. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
[TBL] [Abstract][Full Text] [Related]
13. Correlation of serum fatty acid binding protein-4 and interleukin-6 with airflow limitation and quality of life in stable and acute exacerbation of COPD.
Aslani MR; Ghazaei Z; Ghobadi H
Turk J Med Sci; 2020 Apr; 50(2):337-345. PubMed ID: 31905499
[TBL] [Abstract][Full Text] [Related]
14. Association of Plasma Heat Shock Protein 70 with Disease Severity, Smoking and Lung Function of Patients with Chronic Obstructive Pulmonary Disease.
Hlapčić I; Hulina-Tomašković A; Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rumora L
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32992869
[TBL] [Abstract][Full Text] [Related]
15. Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD.
Luo Y; Zhou L; Li Y; Guo S; Li X; Zheng J; Zhu Z; Chen Y; Huang Y; Chen R; Chen X
Respir Care; 2016 May; 61(5):680-8. PubMed ID: 26814217
[TBL] [Abstract][Full Text] [Related]
16. Correlations Between Serum Decoy Receptor 3 and Airflow Limitation and Quality of Life in Male Patients with Stable Stage and Acute Exacerbation of COPD.
Ghobadi H; Hosseini N; Aslani MR
Lung; 2020 Jun; 198(3):515-523. PubMed ID: 32211977
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PVT1, a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA-146a.
Wang Y; Lyu X; Wu X; Yu L; Hu K
J Clin Lab Anal; 2020 Aug; 34(8):e23346. PubMed ID: 32342557
[TBL] [Abstract][Full Text] [Related]
18. The Neutrophil to Lymphocyte Ratio Is Related to Disease Severity and Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.
Furutate R; Ishii T; Motegi T; Hattori K; Kusunoki Y; Gemma A; Kida K
Intern Med; 2016; 55(3):223-9. PubMed ID: 26831014
[TBL] [Abstract][Full Text] [Related]
19. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
[TBL] [Abstract][Full Text] [Related]
20. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
